These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Miki J; Rhim JS Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999 [TBL] [Abstract][Full Text] [Related]
24. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? Sánchez-García I; Vicente-Dueñas C; Cobaleda C Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789 [TBL] [Abstract][Full Text] [Related]
25. Strategies for cancer stem cell elimination: insights from mathematical modeling. Vainstein V; Kirnasovsky OU; Kogan Y; Agur Z J Theor Biol; 2012 Apr; 298():32-41. PubMed ID: 22210402 [TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells: lessons from leukemia. Wang JC; Dick JE Trends Cell Biol; 2005 Sep; 15(9):494-501. PubMed ID: 16084092 [TBL] [Abstract][Full Text] [Related]
27. The search for multiple myeloma stem cells: the long and winding road. Basak GW; Carrier E Biol Blood Marrow Transplant; 2010 May; 16(5):587-94. PubMed ID: 19895894 [TBL] [Abstract][Full Text] [Related]
28. [Progress in the study of brain tumor stem cells as treatment targets]. Hide T; Kuratsu J Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855 [TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; La Noce M; Laino L; De Francesco F; Papaccio G FASEB J; 2013 Jan; 27(1):13-24. PubMed ID: 23024375 [TBL] [Abstract][Full Text] [Related]
30. Pluripotent human stem cell lines: what we can learn about cancer initiation. Werbowetski-Ogilvie TE; Bhatia M Trends Mol Med; 2008 Aug; 14(8):323-32. PubMed ID: 18635398 [TBL] [Abstract][Full Text] [Related]
31. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Glinsky GV J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963 [TBL] [Abstract][Full Text] [Related]
33. Cancer stem cells in urologic cancers. Gedye C; Davidson AJ; Elmes MR; Cebon J; Bolton D; Davis ID Urol Oncol; 2010; 28(6):585-90. PubMed ID: 19897386 [TBL] [Abstract][Full Text] [Related]
34. Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds. Maiuthed A; Chantarawong W; Chanvorachote P Anticancer Res; 2018 Jul; 38(7):3797-3809. PubMed ID: 29970499 [TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells. From characterization to therapeutic implications. Alajez NM Saudi Med J; 2011 Dec; 32(12):1229-34. PubMed ID: 22159375 [TBL] [Abstract][Full Text] [Related]
36. Lung cancer stem cells, p53 mutations and MDM2. Gadepalli VS; Deb SP; Deb S; Rao RR Subcell Biochem; 2014; 85():359-70. PubMed ID: 25201204 [TBL] [Abstract][Full Text] [Related]
37. Lung Cancer Stem Cells: An Epigenetic Perspective. Shukla S; Khan S; Sinha S; Meeran SM Curr Cancer Drug Targets; 2018; 18(1):16-31. PubMed ID: 28176651 [TBL] [Abstract][Full Text] [Related]
38. [Progress of research on non-small cell lung cancer stem cell]. Cao BS; Ren J Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):555-7. PubMed ID: 18931724 [TBL] [Abstract][Full Text] [Related]
39. Pluripotency transcription factors in lung cancer-a review. Sławek S; Szmyt K; Fularz M; Dziudzia J; Boruczkowski M; Sikora J; Kaczmarek M Tumour Biol; 2016 Apr; 37(4):4241-9. PubMed ID: 26581906 [TBL] [Abstract][Full Text] [Related]